Dapsone | A sulfone drug used to treat acne vulgaris, Hansen's disease, and dermatitis herpetiformis. |
Sildenafil | A phosphodiesterase inhibitor used for the treatment of erectile dysfunction. |
Dofetilide | A class III antiarrhythmic drug used for the maintenance of normal sinus rhythm and cardioversion in cases of atrial fibrillation and atrial flutter. |
Torasemide | A diuretic used to treat hypertension and edema associated with heart failure, renal failure, or liver disease. |
Glimepiride | A sulfonylurea drug used to treat type 2 diabetes mellitus. |
Methyclothiazide | A diuretic drug used to treat hypertension and edema caused by heart failure, renal conditions, treatment with corticosteroids, and estrogen therapy. |
Sulfanilamide | A sulfonamide anti-infective used to treat vulvovaginal candidiasis caused by Candida albicans. |
Sulfisoxazole | A sulfonamide antibiotic used with other antibiotics to prevent and treat a variety of bacterial infections. |
Ibutilide | A class III antiarrhythmic agent used to correct atrial fibrillation and atrial flutter, which can be considered as an alternative to cardioversion. |
Chlorthalidone | A diuretic used to treat hypertension or edema caused by heart failure, renal failure, hepatic cirrhosis, estrogen therapy, and other conditions. |
Ethoxzolamide | For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy. |
Sulfadiazine | A sulfonamide antibiotic used in a variety of infections, such as urinary tract infections, trachoma, and chancroid. |
Acetohexamide | Used in the management of diabetes mellitus type 2 (adult-onset). |
Bendroflumethiazide | A diuretic used to suppress lactation and to treat hypertension and edema. |
Celecoxib | An NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, menstrual symptoms, and to reduce polyps is familial adenomatous polyposis. |
Metolazone | A thiazide-like diuretic used to treat hypertension. |
Zafirlukast | A leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma. |
Bosentan | A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension. |
Benzthiazide | For the treatment of high blood pressure and management of edema. |
Sulfamethizole | A sulfonamide antibiotic used to treat a wide variety of susceptible bacterial infections. |
Valdecoxib | A COX-2 inhibitor used to treat osteoarthritis and dysmenorrhoea. |
Cyclothiazide | Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either... |
Sulfacetamide | A corticosteroid used to treat inflammatory ocular conditions and acne vulgaris. |
Sulfametopyrazine | For the treatment of urinary tract infection and chronic bronchitis. |
Sumatriptan | A serotonin receptor agonist used to treat migraines and cluster headaches. |
Chlorpropamide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
Furosemide | A loop diuretic used to treat hypertension and edema in congestive heart failure, liver cirrhosis, renal disease, and hypertension. |
Amprenavir | A protease inhibitor used to treat HIV infection. |
Tamsulosin | An alpha-1A and alpha-1B adrenergic receptor antagonist used to treat benign prostatic hyperplasia, ureteral stones, prostatitis, and female voiding dysfunction. |
Hydroflumethiazide | A thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure and liver cirrhosis. |
Sulfasalazine | An anti-inflammatory drug used to treat Crohn's disease and rheumatoid arthritis. |
Indapamide | A thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure. |
Sodium lauryl sulfate | An anionic surfactant used in cosmetics and pharmaceuticals as a fat emulsifier, wetting agent, and detergent. |
Tolazamide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
Dorzolamide | A carbonic anhydrase inhibitor used to treat high intraocular pressure in ocular hypertension and open angle glaucoma. |
Chlorothiazide | A thiazide diuretic used to treat hypertension and edema in congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. |
Bumetanide | A sulfamyl diuretic used to treat edema in congestive heart failure, hepatic and renal disease, and nephrotic syndrome. |
Sulfapyridine | A sulfonamide antibiotic used to treat dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum. |
Hydrochlorothiazide | A thiazide diuretic used to treat edema associated with a number of conditions, and hypertension. |
Sulfamethoxazole | An oral sulfonamide antibiotic, given in combination with trimethoprim, used to treat a variety of infections of the urinary tract, respiratory system, and gastrointestinal tract. |
Glyburide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
Trichlormethiazide | Used in the treatment of oedema (including that associated with heart failure) and hypertension. |
Probenecid | A medication used to treat gouty arthritis, tophaceous gout, and hyperuricemia. |
Glipizide | A sulfonylurea medication used in Type 2 Diabetes to sensitize pancreatic beta cells and stimulate insulin release. |
Rosuvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
Diazoxide | A non diuretic benzothiadiazine indicated for the management of hypoglycemia in patients who produce an excess of insulin caused by a variety of conditions. |
Gliclazide | A sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
Tolbutamide | A sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
Bicalutamide | An androgen receptor inhibitor used to treat Stage D2 metastatic carcinoma of the prostate. |
Diclofenamide | A carbonic anhydrase inhibitor used for the management of open-angle and secondary glaucoma, as well as acute angle-closure glaucoma in delayed pre-operative setting requiring a reduction in intraocular pressure. |
Sulfoxone | For the treatment of leprosy and dermatitis herpetiformis |
Brinzolamide | A carbonic anhydrase inhibitor used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. |
Gliquidone | Used in the treatment of diabetes mellitus type 2. |
Darunavir | A HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection in patients with history of prior antiretroviral therapies. |
Glisoxepide | For the treatment of diabetes mellitus type 2. |
Sulfacytine | Used orally in the treatment of acute urinary tract infections. |
Sulfadoxine | A long acting sulfonamide used for the treatment or prevention of malaria. |
Fosamprenavir | An antiretroviral agent used for the treatment and postexposure prophylaxis of human immunodeficiency virus (HIV-1) infection. |
Polythiazide | A thiazide diuretic used in the management of hypertension and treatment of edema. |
Quinethazone | Used to treat hypertension. |
Glymidine | Glycodiazine is used concomitantly with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. |
Sulfamerazine | An antibacterial agent used in the treatment of various bacterial infections, such as bronchitis, prostatitis, and urinary tract infections. |
Sulfamethazine | An antibacterial agent used in the treatment of various bacterial infections, such as bronchitis, prostatitis, and urinary tract infections. |
SC-74020 | Not Available |
WAY-151693 | Not Available |
Dansylamide | Not Available |
Piretanide | Piretanide (INN, trade names Arelix, Eurelix, Tauliz) has been synthesized in 1973 at Hoechst AG (Germany) as a loop diuretic compound by using a then-new method for introducing cyclic amine... |
N,O-Didansyl-L-Tyrosine | Not Available |
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide | Not Available |
Hydroxyfasudil | Not Available |
Nimesulide | For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. |
Belinostat | A histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). |
INCB13739 | Investigated for use/treatment in diabetes mellitus type 2 and diabetes prevention. |
SLV319 | Investigated for use/treatment in obesity. |
Cimicoxib | Investigated for use/treatment in depression. |
KD3010 | Investigated for use/treatment in metabolic disease and obesity. |
XL765 | For the treatment of various forms of cancer. |
Silver sulfadiazine | A topical sulfonamide antibiotic that acts on the bacterial cell wall and cell membrane; approved for the treatment of burns. |
Actelion-1 | Investigated for use/treatment in cardiovascular disorders, hypertension, and pulmonary hypertension. |
AMG-131 | Investigated for use/treatment in diabetes mellitus type 2. |
Naluzotan | Investigated for use/treatment in anxiety disorders and depression. |
Laromustine | Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors. |
Resatorvid | Investigated for use/treatment in sepsis and septicemia. |
Sulfathiazole | Sulfathiazole is effective against a wide range of gram positive and gram negative pathogenic microorganisms. Although no longer used in humans, it is used in cattle. |
Sulfadimethoxine | For use in the treatment of infections. |
Udenafil | Investigated for use/treatment in erectile dysfunction and hypertension. |
Simeprevir | A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. |
Refametinib | Investigated for use/treatment in cancer/tumors (unspecified). |
Elinogrel | Investigated for use/treatment in cardiovascular disorders and myocardial infarction. |
Indisulam | Investigated for use/treatment in lung cancer. |
Pazopanib | An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. |
Clazosentan | Investigated for use/treatment in strokes. |
Sulfaphenazole | For the treatment bacterial infections. |
Mafenide | An antimicrobial topical agent indicated for use as an adjunctive treatment to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds. |
Sulfameter | Long acting sulfonamide used in leprosy, urinary, and respiratory tract infections. |
TO-901317 | TO-901317 is an LXRalpha and LXRbeta agonist. |
5-(2-methylpiperazine-1-sulfonyl)isoquinoline | Not Available |
4-(2-AMINOETHYL)BENZENESULFONAMIDE | Not Available |
Pipazethate | For the treatment of cough. |
Sulfamoxole | For the treatment of bacterial infection. |
Vemurafenib | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. |
Macitentan | An endothelin receptor antagonist used to manage pulmonary arterial hypertension to delay disease progression. |
Azosemide | Azosemide is a loop diuretic used to treat hypertension, edema, and ascites. |
Glibornuride | Glibornuride is a sulfonylurea-type anti-diabetic drug. |
Blinatumomab | An antineoplastic antibody used to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). |
Dasabuvir | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. |
Sulfabenzamide | A sulfonamide antibacterial used as an ingredient in various topical and vaginal preparations to treat certain infections, but has been discontinued by the FDA. |
Clorsulon | Not Annotated |
Deracoxib | Deracoxib is a non-steroidal anti-inflammatory drug of the coxib class, used in veterinary medicine to treat osteoarthritis in dogs. It is sold in tablets, which have added beefy flavour to... |
Sulfachlorpyridazine | A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. |
Sulfaethoxypyridazine | Not Annotated |
Sulfanitran | Not Annotated |
Sulfaquinoxaline | Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K... |
Asunaprevir | An NS3 protease inhibitor used to treat hepatitis C genotype 1b. |
Pictilisib | Pictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others. |
Pavinetant | Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia. |
Encorafenib | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. |
Vonoprazan | Vonoprazan has been used in trials studying the treatment of Erosive Esophagitis. |
Pilaralisib | Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors,... |
Danoprevir | Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic. |
Mirodenafil | Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction. |
AZD-5672 | Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis. |
Baricitinib | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. |
TMC-647055 | TMC647055 has been used in trials studying the treatment of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, and Chronic Hepatitis C Virus. |
PF-04958242 | PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural. |
Litronesib | Litronesib has been used in trials studying the treatment of Solid Tumors, Ovarian Cancer, Gastric Cancer, Prostate Cancer, and Acute Leukaemia, among others. |
PF-00610355 | PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others. |
Avagacestat | Avagacestat has been investigated for the basic science and treatment of Alzheimer Disease. |
Gisadenafil | Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia. |
Tasisulam | Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others. |
Setrobuvir | Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic. |
T-900607 | T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer. |
Elubrixin | Elubrixin has been used in trials studying the treatment of Cystic Fibrosis, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease (COPD). |
Presatovir | Presatovir has been used in trials studying the treatment of RSV Infection, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections, and Respiratory Syncytial Virus (RSV) Infections. |
Iguratimod | Iguratimod is under investigation in Rheumatoid Arthritis. |
ABT-751 | ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer. |
Begacestat | Begacestat has been used in trials studying the treatment and basic science of Alzheimer Disease. |
Vidupiprant | Vidupiprant has been used in trials studying the treatment and basic science of Asthma. |
Navitoclax | Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others.
Navitoclax is... |
Apricoxib | Apricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, and Metastatic Pancreatic Cancer, among others. |
Resminostat | Resminostat has been used in trials studying the treatment of Sezary Syndrome, Mycosis fungoides, Hodgkin's Lymphoma, Hepatocellular Carcinoma, and Lymphoma, T-Cell, Cutaneous, among others. |
Polmacoxib | Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee. |
Voxtalisib | Voxtalisib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Breast Cancer, among others. |
Fedratinib | Fedratinib is indicated to treat adults with primary or secondary myelofibrosis that is either intermediate-2 or high risk. |
E-7820 | E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer. |
Reparixin | Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type 1, and Pancreatic... |
Taprenepag | Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle. |
Ibipinabant | Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes. |
Omipalisib | Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis. |
Mibampator | Mibampator has been used in trials studying the treatment of Alzheimer's Disease. |
CHF-6001 | CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease. |
Ataciguat | Ataciguat has been investigated for the basic science of Aortic Valve Stenosis. |
Grapiprant | The effects of grapiprant have been investigated in the area of analgesia and anti-inflammation due to the effects that have been reported about this molecule. This molecule has been approved... |
Sivelestat | Sivelestat has been used in trials studying the treatment of Acute Lung Injury and Respiratory Distress Syndrome, Adult. |
Chlorsulfaquinoxaline | Chlorsulfaquinoxaline has been used in trials studying the treatment of Lung Cancer and Colorectal Cancer. |
Ramatroban | Ramatroban has been used in trials studying the treatment of Asthma. |
CH-5132799 | CH5132799 has been used in trials studying the treatment of Solid Tumors. |
Upamostat | Upamostat has been used in trials studying the treatment of Pancreatic Cancer. |
Ripasudil | Ripasudil has been proven to be effective in the twice daily treatment of glaucoma and ocular hypertension. It is currently in studies to be approved for both diabetic retinopathy and... |
Phthalylsulfathiazole | Phthalylsulfathiazole is a broad spectrum antibiotic which is part of the drug class, sulfonamides. It was used as an antibiotic for bowel surgery, and for infections of the colon . |
Sulfaisodimidine | Sulfaisodimidine also called sulfisomidine is an antibacterial product that has been studied for the treatment of urinary tract infections in the 1950s, however, it is unclear whether this drug has... |
Mefruside | Not Annotated |
Carbutamide | Not Annotated |
Mebutizide | Not Annotated |
Cyclopenthiazide | Cyclopenthiazide is a thiazide diuretic with antihypertensive properties. In a double blind, randomized crossover study, cyclopenthiazide was effective in reducing diastolic blood pressure in mildly hypertensive non-insulin dependent diabetic patients... |
Sulfatolamide | Not Annotated |
Succinylsulfathiazole | Not Annotated |
Clorexolone | Not Annotated |
Metahexamide | Not Annotated |
Sulfathiourea | Not Annotated |
Sulfaguanidine | Not Annotated |
Sulfamethoxypyridazine | Not Annotated |
Clopamide | Clopamide is an oral diuretic agent with antihypertensive activity. Like thiazide diuretics, it has an aromatic sulfonamide base but with no double-ring structure. |
Xipamide | Not Annotated |
SB-269970 | SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist... |
Acetyl sulfisoxazole | Acute, recurrent or chronic urinary tract infections (primarily pyelonephritis, pyelitis and cystitis) due to susceptible organisms (usually Escherichia coli, Klebsiella-Enterobacter, staphylococcus, Proteus mirabilis and, less frequently, Proteus vulgaris) in the... |
SC-236 | SC-236 is a potent, selective, orally active inhibitor of cyclooxygenase-2 (COX-2) that has been studied in cancer therapy , lower back pain , and inflammation , , , . |
NS-398 | NS-398 is a COX-2 inhibitor. It was developed as part of the mechanistic study of the cyclooxygenases. |
Estradiol sulfamate | Investigated for use/treatment in endometriosis. |
Tosylchloramide | Tosylchloramide, also known as chloramine-T, is a chlorinated and deprotonated sulfonamide used as a mild disinfectant. It is not stable in the water dissolved form. |
Nesbuvir | Nesbuvir has been investigated for the treatment of Hepatitis C. |
Fasudil | Fasudil has been investigated in Carotid Stenosis. |
Venetoclax | A BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. |
ABT-639 | ABT-639 is under investigation in clinical trial NCT01345045 (A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain). |
Aprocitentan | Aprocitentan is under investigation in clinical trial NCT03541174 (A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and... |
Dubermatinib | Dubermatinib is under investigation in clinical trial NCT03572634 (Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL). |
JNJ-26489112 | JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy). |
Vercirnon | Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. It is... |
Florasulam | Florasulam is under investigation in clinical trial NCT01193465 (Temperature and Humidity Among Different Anesthesia Work-station). |
VM4-037 | VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037). |
Giripladib | Giripladib is under investigation in clinical trial NCT00396955 (A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee). |
Zonisamide | A sulfonamide anticonvulsant used to treat partial seizures. |
Tazobactam | A beta lactamase inhibitor administered with antibiotics such as piperacillin and ceftolozane to prevent their degradation, resulting in increased efficacy. |
Etoricoxib | For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. |
Epacadostat | Epacadostat has been used in trials studying the treatment of HL, Melanoma, Glioblastoma, Mucosal Melanoma, and Ovarian Carcinoma, among others. |
PF-00489791 | PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic Nephropathies, Hypertension, Pulmonary, and Peripheral Vascular Disease. |
Voxilaprevir | A nonstructural protein 3 and 4a protease inhibitor used to treat Hepatitis C infections. |
Defactinib | Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma. |
GLPG-0187 | GLPG0187 has been used in trials studying the treatment of Solid Tumors. |
Glecaprevir | A Hepatitis C NS3/4A protease inhibitor used to treat Hepatitis C. |
Lanifibranor | Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337). |
PF-05089771 | PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). |
TAK-243 | TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia). |
ABT-072 | ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat... |
PLX-4720 | Not Available |
GW-813893 | Not Available |
CGS-27023 | Not Available |
H-89 | Not Available |
Fasitibant | Fasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee). |
Buthiazide | Not Annotated |
Sulfametrole | Not Annotated |
PLX8394 | PLX8394 is under investigation in clinical trial NCT02428712 (A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors). |
APG-1387 | APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B). |
Batabulin | Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients). |
Ladarixin | Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual Β-Cell Function). |
Mitapivat | Mitapivat is under investigation in clinical trial NCT03548220 (A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)). |